Philips and Masimo today announced that the two companies have renewed their multi-year strategic collaboration.
The expanded partnership includes a joint effort to integrate Masimo’s monitoring technologies – including SET pulse oximetry, Radius PPG, and a range of sensor technology – into Philips’ multi-parameter patient monitoring platforms. This integration supports clinicians with data and actionable insights across bedside monitors, central stations, and wearable solutions, while giving them the flexibility to use their preferred measurement technologies within a single, unified system.
Building on this foundation, Philips and Masimo also plan to collaborate on the development and co-promotion of monitoring solutions that reflect emerging clinical needs and evolving market demands such as the need for greater patient mobility. These efforts will focus on advancing connected care and expanding access to technologies including AI algorithms.
“Our priority is helping clinicians deliver the best possible care to their patients, and that means staying ahead of the curve,” said Julia Strandberg, Executive Vice President and Business Leader Connected Care at Royal Philips. “This partnership allows us to respond quickly to evolving clinical needs and market trends, integrating proven technologies into solutions that are easy to use, reliable, and scalable.”
“We are excited to continue to partner with Philips to bring Masimo’s newest innovations in wearables and artificial intelligence to Philips’ platforms,” said Katie Szyman, CEO of Masimo. “Expanding our strong, long-standing partnership with Philips allows us to build on our shared legacies of innovation and helps ensure that Masimo’s best-in-class technologies reach even more patients. Together, Masimo and Philips will continue to empower clinicians to transform patient care.”
